Abacavir, Lamivudine, and Zidovudine

Discover **Abacavir Lamivudine Zidovudine**, a potent triple therapy for HIV-1 infection. Understand its mechanism, uses, dosage, and side effects for effe

Abacavir Lamivudine Zidovudine HIV triple therapy Abacavir Lamivudine Zidovudine dosage HIV antiretroviral drugs Nucleoside reverse transcriptase inhibitors HIV treatment side effects Managing HIV with FDC Abacavir hypersensitivity reaction Antiretroviral combination therapy
🏷 ATC Code: J05AR04 📂 Antivirals for treatment of HIV infections, combinations 🕐 Updated: Mar 13, 2026 ✓ Medical Reference

Looking to order Abacavir, Lamivudine, and Zidovudine?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Abacavir, Lamivudine, and Zidovudine?

Abacavir Lamivudine Zidovudine is a fixed-dose combination medication used to treat human immunodeficiency virus type 1 (HIV-1 infection). It combines three powerful antiretroviral drugs: Abacavir, Lamivudine, and Zidovudine, all belonging to a class of medications called **nucleoside reverse transcriptase inhibitors (NRTIs)**. This combination provides a comprehensive approach to managing HIV by targeting the virus at different stages of its replication cycle. It is an essential component of modern **antiretroviral therapy (ART)**, designed to significantly improve the quality of life and prognosis for individuals living with HIV.

This medication is not a cure for HIV but helps to control the virus, reduce the amount of HIV in the body (known as the **viral load**), and increase the number of CD4 cells, which are crucial for the immune system. By keeping the viral load low, it helps prevent the progression of HIV to AIDS and reduces the risk of transmitting the virus to others.

How Does it Work?

The three active ingredients in this combination medication – Abacavir, Lamivudine, and Zidovudine – are all NRTIs. Their mechanism of action involves interfering with a crucial enzyme called reverse transcriptase, which the HIV virus uses to convert its RNA into DNA. This step is vital for the virus to integrate its genetic material into the host cell's DNA and replicate.

  • Abacavir: Once inside the body, Abacavir is converted into its active form, carbovir triphosphate. This active metabolite then competes with natural nucleosides, inhibiting reverse transcriptase and terminating the growing viral DNA chain.
  • Lamivudine: Similar to Abacavir, Lamivudine is phosphorylated into lamivudine triphosphate. This molecule acts as a false building block for the viral DNA, causing premature termination of the DNA chain synthesis by reverse transcriptase.
  • Zidovudine: Zidovudine, also known as AZT, was one of the first antiretroviral drugs developed. It is converted to zidovudine triphosphate, which also acts as a chain terminator for the viral DNA by inhibiting reverse transcriptase.

By effectively blocking reverse transcriptase, these NRTIs prevent the HIV virus from replicating, thereby reducing the viral load and allowing the immune system to recover. The combination of these three drugs offers enhanced antiviral activity and helps to minimize the development of drug resistance.

Medical Uses

The primary medical use of Abacavir Lamivudine Zidovudine is the treatment of **HIV-1 infection** in adults and adolescents. It is typically prescribed as part of a comprehensive ART regimen. This fixed-dose combination simplifies treatment by reducing the pill burden, which can improve patient adherence.

The goals of using this medication include:

  • Reducing Viral Load: Significantly decreasing the amount of HIV in the bloodstream to undetectable levels.
  • Increasing CD4 Cell Count: Restoring and maintaining the immune system by increasing the number of **CD4 cell count**, which are critical immune cells targeted by HIV.
  • Preventing Disease Progression: Slowing down or preventing the development of AIDS-defining illnesses and opportunistic infections.
  • Improving Quality of Life: Enhancing overall health and well-being for individuals living with HIV.
  • Preventing Transmission: Reducing the risk of HIV transmission to sexual partners (as part of a 'treatment as prevention' strategy) and from mother to child during pregnancy and childbirth.

It is crucial that this medication is used under the guidance of a healthcare professional experienced in managing HIV infection.

Dosage

The standard dosage for Abacavir Lamivudine Zidovudine typically involves a fixed-dose tablet containing Abacavir 300 mg, Lamivudine 150 mg, and Zidovudine 300 mg. The usual adult dosage is one tablet taken twice daily. However, specific dosing instructions may vary based on individual patient factors, such as kidney function, body weight, and the presence of other medical conditions or medications.

It is paramount to follow the exact dosage and schedule prescribed by your doctor. Missing doses can lead to the development of drug resistance, making the treatment less effective. This medication can be taken with or without food. If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next dose, in which case the missed dose should be skipped.

Before initiating Abacavir-containing regimens, all patients must undergo screening for the HLA-B*5701 allele. Patients who test positive for this allele are at a significantly higher risk of developing a severe and potentially life-threatening hypersensitivity reaction to Abacavir, and should therefore not receive this medication.

Side Effects

Like all medications, Abacavir Lamivudine Zidovudine can cause side effects. Some common side effects include:

  • Nausea, vomiting, diarrhea
  • Headache
  • Fatigue or weakness
  • Dizziness
  • Difficulty sleeping (insomnia)
  • Skin rash

More serious, though less common, side effects can occur. It is crucial to be aware of these and seek immediate medical attention if they arise:

  • Abacavir Hypersensitivity Reaction: This is a severe, potentially life-threatening allergic reaction. Symptoms often include fever, rash, nausea, vomiting, diarrhea, abdominal pain, severe tiredness, body aches, or shortness of breath. If these symptoms occur, the medication must be stopped immediately, and medical help sought. Re-challenge with Abacavir after a hypersensitivity reaction can be fatal.
  • Lactic Acidosis and Severe Hepatomegaly with Steatosis: This is a rare but serious condition, particularly with NRTIs, characterized by a buildup of lactic acid in the blood and an enlarged liver with fat accumulation. Symptoms include unusual muscle pain, shortness of breath, stomach pain, dizziness, and feeling cold.
  • Bone Marrow Suppression: Zidovudine can cause a decrease in red blood cells (anemia), white blood cells (neutropenia), and platelets (thrombocytopenia), requiring regular blood monitoring.
  • Liver Problems: Especially in patients with pre-existing liver disease.
  • Pancreatitis: Inflammation of the pancreas.

Always discuss any concerns about side effects with your healthcare provider.

Drug Interactions

Abacavir Lamivudine Zidovudine can interact with various other medications, potentially altering their effectiveness or increasing the risk of side effects. It is vital to inform your doctor about all prescription, over-the-counter, and herbal supplements you are taking.

Key drug interactions to be aware of include:

  • Other Antiretroviral Drugs: Caution is advised when co-administering with certain other NRTIs or other classes of antiretrovirals due to potential additive toxicities or altered drug levels.
  • Drugs Affecting Bone Marrow: Medications that can suppress bone marrow function (e.g., ganciclovir, interferon alpha, dapsone) may increase the risk of hematological toxicity when taken with Zidovudine.
  • Methadone: Abacavir can decrease methadone levels, potentially requiring dose adjustment of methadone.
  • Ribavirin: Co-administration with Ribavirin is not recommended in patients with anemia, as it can worsen Zidovudine-induced anemia.
  • Trimethoprim/Sulfamethoxazole: High doses of this antibiotic combination may increase Lamivudine levels.
  • Sorbitol: Co-administration with sorbitol-containing medicines can decrease Lamivudine and Abacavir exposure.

This is not an exhaustive list. Always consult your pharmacist or doctor for a complete list of potential interactions.

FAQ

Is Abacavir, Lamivudine, and Zidovudine a cure for HIV?

No, Abacavir Lamivudine Zidovudine is not a cure for HIV. It is an antiretroviral medication that helps to control the virus, reduce the viral load, and improve the immune system, but it does not eliminate HIV from the body. It must be taken consistently for life to manage the infection effectively.

Why is genetic testing for HLA-B*5701 allele important before starting Abacavir?

Genetic testing for the HLA-B*5701 allele is crucial because individuals who carry this gene have a significantly higher risk of developing a severe and potentially fatal hypersensitivity reaction to Abacavir. If you test positive, your doctor will prescribe an alternative HIV medication to ensure your safety.

Can pregnant women use this medication?

The use of Zidovudine, Lamivudine, and Abacavir during pregnancy is a complex decision that must be made in consultation with a healthcare provider. While Zidovudine has been used to reduce mother-to-child transmission, the overall safety and benefits of this specific combination during pregnancy need careful evaluation. Your doctor will weigh the risks and benefits to you and your baby.

How long do I need to take this medication?

For most individuals, treatment with Abacavir Lamivudine Zidovudine or other ART regimens is lifelong. Consistent adherence to the prescribed medication schedule is essential to maintain viral suppression, prevent the progression of HIV disease, and avoid the development of drug resistance.

Products containing Abacavir, Lamivudine, and Zidovudine are available through trusted online pharmacies. You can browse Abacavir, Lamivudine, and Zidovudine-based medications at ShipperVIP or Medicenter.

Summary

Abacavir Lamivudine Zidovudine is a powerful fixed-dose combination medication comprising three **nucleoside reverse transcriptase inhibitors (NRTIs)**: Abacavir, Lamivudine, and Zidovudine. It is a cornerstone of **HIV triple therapy** and **antiretroviral therapy (ART)**, designed to effectively manage **HIV-1 infection** by inhibiting viral replication, reducing **viral load**, and restoring the immune system's **CD4 cell count**. While not a cure, it significantly improves health outcomes and quality of life for individuals living with HIV.

Patients must undergo HLA-B*5701 screening before starting treatment due to the risk of severe hypersensitivity reactions to Abacavir. Adherence to the prescribed dosage, awareness of potential side effects (including serious ones like lactic acidosis and bone marrow suppression), and careful management of drug interactions are crucial for safe and effective treatment. Regular monitoring by a healthcare professional is essential to optimize therapy and address any concerns. This medication represents a vital tool in the ongoing fight against HIV, helping individuals live longer, healthier lives.